Vaginal surgical mesh: Risks

The risks associated with using a health product can arise from several factors, including the:

We regulate surgical mesh according to the Food and Drugs Act and the Medical Devices Regulations. We have classified non-absorbable synthetic mesh as a Class III medical device. This is the second-highest risk class of medical devices.

Use of transvaginal mesh for the treatment of pelvic organ prolapse (POP) and/or stress urinary incontinence (SUI) has been associated with reports of:

With the exception of mesh erosion, such complications can also occur after a non-mesh procedure.

Removing mesh or fixing mesh-related complications may require 1 or more surgeries. In some cases, complete removal may not be feasible. Additional surgery may not correct some complications. This is because tissues can grow around the mesh by the time the complications appear, making full removal of the mesh difficult or impossible.

The use of transvaginal mesh for the treatment of POP and SUI share similar risks and complications, but there is a difference in their associated:

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: